MBD following kidney transplantation is common and characterized by loss of bone volume
and mineralization abnormalities, often leading to low turnover bone disease. Although …

Mineral and bone diseases (MBD) are common in patients with chronic kidney disease who
undergo kidney transplantation. The incidence, types and severity of MBD vary according to …

Background The assessment and prevention of mineral and bone disorder (MBD) in kidney
transplant recipients (KTRs) have not been standardized. This study aimed to evaluate MBD …

Renal transplantation (RTx) allows us to obtain the resolution of the uremic status but is not
frequently able to solve all the metabolic complications present during end-stage renal …

The management of post‐transplantation bone disease is a complex problem that remains
under‐appreciated in clinical practice. In these patients, pre‐existing metabolic bone …

Background/Aims: Abnormal bone and mineral metabolism is common in patients with
kidney failure and often persists after successful kidney transplant. Methods: To better …

Abstract Purpose of Review Despite metabolic improvements following kidney
transplantation, transplant recipients still often suffer from complex mineral and bone …

Kidney transplantation, the most effective treatment for the metabolic abnormalities of
chronic kidney disease (CKD), only partially corrects CKD–mineral and bone disorders …

Chronic kidney disease-mineral bone disorder (CKD-MBD) after kidney transplantation is a
mix of pre-existing disorders and new alterations. The final consequences are reflected …

After kidney transplantation, mineral and bone disorders are associated with higher risk of
fractures and consequent morbidity and mortality. Disorders of calcium and phosphorus …